Uniparental and functional X disomy in Turner syndrome patients with unexplained mental retardation and X derived marker chromosomes. 1998

T Yorifuji, and J Muroi, and M Kawai, and A Uematsu, and H Sasaki, and T Momoi, and M Kaji, and C Yamanaka, and K Furusho
Department of Paediatrics, Kyoto University Hospital, Japan.

We analysed parental origin and X inactivation status of X derived marker (mar(X)) or ring X (r(X)) chromosomes in six Turner syndrome patients. Two of these patients had mental retardation of unknown cause in addition to the usual Turner syndrome phenotype. By FISH analysis, the mar(X)/r(X) chromosomes of all patients retained the X centromere and the XIST locus at Xq13.2. By polymorphic marker analysis, both patients with mental retardation were shown to have uniparental X disomy while the others had both a maternal and paternal contribution of X chromosomes. By RT-PCR analysis and the androgen receptor assay, it was shown that in one of these mentally retarded patients, the XIST on the mar(X) was not transcribed and consequently the mar(X) was not inactivated, leading to functional disomy X. In the other patient, the XIST was transcribed but the r(X) appeared to be active by the androgen receptor assay. Our results suggest that uniparental disomy X may not be uncommon in mentally retarded patients with Turner syndrome. Functional disomy X seems to be the cause of mental retardation in these patients, although the underlying molecular basis could be diverse. In addition, even without unusual dysmorphic features, Turner syndrome patients with unexplained mental retardation need to be investigated for possible mosaicism including these mar(X)/r(X) chromosomes.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008297 Male Males
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D009030 Mosaicism The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from a single ZYGOTE, as opposed to CHIMERISM in which the different cell populations are derived from more than one zygote.
D009035 Mothers Female parents, human or animal. Mothers' Clubs,Club, Mothers',Clubs, Mothers',Mother,Mother Clubs,Mother's Clubs,Mothers Clubs,Mothers' Club
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011944 Receptors, Androgen Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA. Androgen Receptors,5 alpha-Dihydrotestosterone Receptor,Androgen Receptor,Dihydrotestosterone Receptors,Receptor, Testosterone,Receptors, Androgens,Receptors, Dihydrotestosterone,Receptors, Stanolone,Stanolone Receptor,Testosterone Receptor,5 alpha Dihydrotestosterone Receptor,Androgens Receptors,Receptor, 5 alpha-Dihydrotestosterone,Receptor, Androgen,Receptor, Stanolone,Stanolone Receptors,alpha-Dihydrotestosterone Receptor, 5
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D004303 Dosage Compensation, Genetic Genetic mechanisms that allow GENES to be expressed at a similar level irrespective of their GENE DOSAGE. This term is usually used in discussing genes that lie on the SEX CHROMOSOMES. Because the sex chromosomes are only partially homologous, there is a different copy number, i.e., dosage, of these genes in males vs. females. In DROSOPHILA, dosage compensation is accomplished by hypertranscription of genes located on the X CHROMOSOME. In mammals, dosage compensation of X chromosome genes is accomplished by random X CHROMOSOME INACTIVATION of one of the two X chromosomes in the female. Dosage Compensation (Genetics),Gene Dosage Compensation,Hypertranscription, X-Chromosome,X-Chromosome Hypertranscription,Compensation, Dosage (Genetics),Compensation, Gene Dosage,Compensation, Genetic Dosage,Dosage Compensation, Gene,Gene Dosage Compensations,Genetic Dosage Compensation,Genetic Dosage Compensations,Hypertranscription, X Chromosome,X Chromosome Hypertranscription
D005220 Fathers Male parents, human or animal. Father

Related Publications

T Yorifuji, and J Muroi, and M Kawai, and A Uematsu, and H Sasaki, and T Momoi, and M Kaji, and C Yamanaka, and K Furusho
June 1977, The New England journal of medicine,
T Yorifuji, and J Muroi, and M Kawai, and A Uematsu, and H Sasaki, and T Momoi, and M Kaji, and C Yamanaka, and K Furusho
January 2002, Cytogenetic and genome research,
T Yorifuji, and J Muroi, and M Kawai, and A Uematsu, and H Sasaki, and T Momoi, and M Kaji, and C Yamanaka, and K Furusho
January 1980, American journal of medical genetics,
T Yorifuji, and J Muroi, and M Kawai, and A Uematsu, and H Sasaki, and T Momoi, and M Kaji, and C Yamanaka, and K Furusho
September 1979, Human genetics,
T Yorifuji, and J Muroi, and M Kawai, and A Uematsu, and H Sasaki, and T Momoi, and M Kaji, and C Yamanaka, and K Furusho
December 1978, The New England journal of medicine,
T Yorifuji, and J Muroi, and M Kawai, and A Uematsu, and H Sasaki, and T Momoi, and M Kaji, and C Yamanaka, and K Furusho
June 1980, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
T Yorifuji, and J Muroi, and M Kawai, and A Uematsu, and H Sasaki, and T Momoi, and M Kaji, and C Yamanaka, and K Furusho
January 1979, Cytogenetics and cell genetics,
T Yorifuji, and J Muroi, and M Kawai, and A Uematsu, and H Sasaki, and T Momoi, and M Kaji, and C Yamanaka, and K Furusho
October 2002, Journal of medical genetics,
T Yorifuji, and J Muroi, and M Kawai, and A Uematsu, and H Sasaki, and T Momoi, and M Kaji, and C Yamanaka, and K Furusho
January 1995, European journal of human genetics : EJHG,
T Yorifuji, and J Muroi, and M Kawai, and A Uematsu, and H Sasaki, and T Momoi, and M Kaji, and C Yamanaka, and K Furusho
March 1979, American journal of human genetics,
Copied contents to your clipboard!